An underground economy for unapproved slimming drugs is being driven by social media fitness personalities and sellers on messaging platforms, according to recent findings.
Experimental Drug Acquiring Traction Via Social Media
Retatrutide, which is still in research studies, is being promoted by online personalities for its alleged weight-reducing effects. Viewers are encouraged to contact these accounts privately for supplier links, while also obtaining promotional offers.
Thriving Trade on Social Networks
Separately, a robust trade exists on Telegram, where groups with thousands of members share comparison photos, injection guides and claims of next-day British shipping. Vendors promote the drug there before redirecting customers to other platforms for transactions.
Learning About The Experimental Drug
Retatrutide is an experimental injection created by US drugmaker Eli Lilly. The drug targets three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies indicate it could help patients reduce up to a quarter of their body weight. Referred to as the “triple G”, the substance is being hailed online as the successor to Ozempic.
Medical Professionals Voice Concerns
Nevertheless, physicians and chemists have cautions that the distribution of what remains an unapproved medication in the United Kingdom is a cause for concern and could result in individuals administering products of unknown origin.
Some experts stated the popularity for the experimental drug could be connected to the rising price of licensed weight loss treatments such as Mounjaro.
Regulatory Position and Implementation
Marketing retatrutide on TikTok or messaging apps is illegal in the United Kingdom, as it is an unapproved medication that must not be marketed or distributed for human use under the British medical regulations.
Some influencers attempt to circumvent the regulations by calling to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled substance, but advertising and distribution can still breach medicines, marketing, and consumer regulations, risking penalties, prosecution or imprisonment.
Platform Response and Content Elimination
According to the social media company, the platform has removed violative content and banned related hashtags and search suggestions. The company said it was committed to maintaining the platform safe and investing in strengthening enforcement strategies.
Online Marketplace Operations
Investigations also found groups with up to 9,000 participants selling retatrutide using Telegram's integrated search feature, which functions like a public directory. Entering “retatrutide” immediately brings up channels with thousands of users, filled with images of slimming results, glowing testimonials and detailed instructions for mixing or administering at home.
Within moments of entering one community, a seller posted WhatsApp details, where most transactions occur. The vendor provided an instruction manual and promised delivery within 48 hours. When asked whether the product was authentic, one seller responded: “You can’t be sure.” Another provided a photo of a supposed testing documentation. None asked about weight, medical conditions or past usage.
Product Details and Pricing
Within these groups, posts display black plastic packages with postal service labels, stating to include fresh supplies. One message read: “It took eight of us to load them this morning.”
Buyers can select between dry substance containers, mixed at home with purified liquid, or pre-filled injectors usually priced at 160 pounds for 20 milligrams. When asked how long a injector should be used, vendors give contradictory responses varying between a several days to “depends on your body”.
Platform Moderation and Security Actions
A representative for the messaging service stated it regularly monitored harmful material on its service including material that encouraged the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.
Medical Professional Warnings
“People are administering materials they can’t verify. Although the research behind this drug is valid, these online versions may not include what they advertise,” stated Jason Murphy, the head of pharmacy at a pharmacy service.
Dr Crystal Wyllie of Asda Online Doctor linked the surge in demand to current cost increases for authorized slimming drugs such as Mounjaro. “With costs increasing, individuals are turning to social media. But counterfeit treatments are extremely dangerous. You can’t be certain what’s inside or whether the conditions they were made in was sterile,” she explained.
Her staff has already seen individuals injured by personal administration from unconfirmed sources. “We recognize the frustration, but purchasing from messaging apps or WhatsApp is taking chances with your well-being,” said Wyllie. “These substances could be impure or incorrectly dosed.”
Manufacturer Statement
A spokesperson from Eli Lilly said retatrutide was in third stage clinical trials and had not been evaluated or approved by any regulatory agency anywhere in the world. “Therefore at this time no one can market [it] for personal consumption,” they said, noting that any item “falsely representing itself as a Lilly investigational product not yet approved … may expose patients to possibly significant medical dangers”.
